CorrectSequence’s CS-101 Shows Promise in Sickle Cell Treatment
CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, today announced the successful...